NO991733L - FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering - Google Patents

FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Info

Publication number
NO991733L
NO991733L NO991733A NO991733A NO991733L NO 991733 L NO991733 L NO 991733L NO 991733 A NO991733 A NO 991733A NO 991733 A NO991733 A NO 991733A NO 991733 L NO991733 L NO 991733L
Authority
NO
Norway
Prior art keywords
preparation
igm
intravenous administration
immunoglobulin
protease
Prior art date
Application number
NO991733A
Other languages
English (en)
Norwegian (no)
Other versions
NO991733D0 (no
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO991733D0 publication Critical patent/NO991733D0/no
Publication of NO991733L publication Critical patent/NO991733L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991733A 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering NO991733L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (2)

Publication Number Publication Date
NO991733D0 NO991733D0 (no) 1999-04-13
NO991733L true NO991733L (no) 1999-06-11

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991733A NO991733L (no) 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Country Status (19)

Country Link
US (1) US6136312A (xx)
EP (1) EP0835880A1 (xx)
JP (1) JP2001504092A (xx)
KR (1) KR20000048826A (xx)
CN (1) CN1233258A (xx)
AU (1) AU725134B2 (xx)
BR (1) BR9712306A (xx)
CA (1) CA2266848A1 (xx)
CZ (1) CZ125599A3 (xx)
HU (1) HUP0001069A3 (xx)
ID (1) ID21364A (xx)
IL (1) IL129383A0 (xx)
NO (1) NO991733L (xx)
NZ (1) NZ334885A (xx)
PL (1) PL332774A1 (xx)
RU (1) RU2191032C2 (xx)
SI (1) SI9720063A (xx)
SK (1) SK46699A3 (xx)
WO (1) WO1998016558A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
DE602004030451D1 (de) 2003-07-15 2011-01-20 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
EP1686137A4 (en) 2003-10-09 2009-10-28 Chugai Pharmaceutical Co Ltd PROCESS FOR STABILIZING PROTEIN SOLUTIONS
EP1688432B1 (en) * 2003-10-09 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Igm high concentration stabilized solution
WO2007106617A2 (en) * 2006-01-30 2007-09-20 Talecris Biotherapeutics, Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
EP2291196A4 (en) * 2008-05-12 2012-05-30 Strox Biopharmaceuticals Llc FOR STAPHYLOCOCCUS AUREUS SPECIFIC ANTIBODY PREPARATIONS
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
NZ726911A (en) 2014-06-03 2023-01-27 Xbiotech Inc Compositions and methods for treating and preventing staphylococcus aureus infections
CN115768789A (zh) * 2020-07-10 2023-03-07 基立福环球运营有限公司 用于获得包含人血浆来源的免疫球蛋白m的组合物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (xx) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
AU4449597A (en) 1998-05-11
NZ334885A (en) 2000-09-29
HUP0001069A2 (hu) 2000-10-28
CN1233258A (zh) 1999-10-27
NO991733D0 (no) 1999-04-13
CZ125599A3 (cs) 1999-07-14
EP0835880A1 (de) 1998-04-15
JP2001504092A (ja) 2001-03-27
BR9712306A (pt) 1999-08-31
CA2266848A1 (en) 1998-04-23
PL332774A1 (en) 1999-10-11
SI9720063A (sl) 1999-08-31
HUP0001069A3 (en) 2000-12-28
WO1998016558A1 (de) 1998-04-23
ID21364A (id) 1999-05-27
US6136312A (en) 2000-10-24
SK46699A3 (en) 2000-06-12
KR20000048826A (ko) 2000-07-25
RU2191032C2 (ru) 2002-10-20
AU725134B2 (en) 2000-10-05
IL129383A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
NO991733L (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
AU5152293A (en) Treatment of autoimmune and inflammatory disorders
DE69535243D1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
FI935585A0 (fi) Pyrrolopyrimidiner
DE69333626D1 (de) Verwendung von Adamantan Derivaten zur Herstellung eines Medikaments zur GLAUKOMBEHANDLUNG
DE69233012D1 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
DE59105609D1 (de) Verwendung von anti-TNF-Antikörpern als Arzneimittel bei der Behandlung von Ischämien und deren Folgen.
DK166763C (da) Immunoglobulin-g-holdig fraktion
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
DE69029858D1 (de) Behandlung von einer autoimmun-krankheit
ZA94333B (en) Synergistic combination of compound having an antogonist effect on NK1 and on NK2 receptors
ES2058343T3 (es) Piridinas disubstituidas.
DK0659082T3 (da) Anvendelse af cytochrom P450 inhibitorer til inhibering af metabolismen af nitrogensubstituerede acridiner
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE1792555A1 (de) Verfahren zur Herstellung von zur intravenoesen Anwendung geeignetem gamma-Globulin
ATE147269T1 (de) Behandlung von männerunfruchtbarkeit
PT65644B (de) Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
EP0705110A4 (en) PERFUSION OF IMMUNOGLOBULINS IN HETEROGRAFTS
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
NO152292C (no) Anlegg for behandling av avvann efter den biologiske aktivslammetode

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application